NICKY TURNER: Open Payments
NPI 1770770133 · LA JUNTA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,648 in 90 payments from 18 companies in 2025. Trend: 2023 $18 · 2024 $2,219 · 2025 $1,648
Food & beverage: $1,648
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $354 |
| Novo Nordisk Inc | 13 | $204 |
| Axsome Therapeutics, Inc. | 4 | $184 |
| AstraZeneca Pharmaceuticals LP | 8 | $146 |
| Lilly USA, LLC | 6 | $96 |
| Radius Health, Inc. | 4 | $82 |
| Sumitomo Pharma America, Inc. | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Vanda Pharmaceuticals Inc. | 4 | $79 |
| Exact Sciences Corporation | 4 | $76 |
Products named: VRAYLAR, Auvelity, REXULTI, MOUNJARO, BREZTRI, GEMTESA, Wegovy, FANAPT.
Industry payments across CO — which companies pay providers there.
